Back to Agenda
Session 6 - Regulatory Reform and ICH implementation in Asian Countries
Session Chair(s)
Junko Sato, PhD
Associate Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
Regulatory Reform in National Medical Product Administration of China
Carol Zhu, MBA
Vice President, Portfolio and Project Management, JW Therapeutics, China
NMPA Regulatory Reform - Recent Challenges at Pharmaceutical Companies -
Tetsuomi Takano, RPh
Editor-in-Chief, Drug R&D Expert, Japan
Regulatory Reform and the ICH Implementation Status
Eun Kyung Kim
, Ministry of Food and Drug Safety, Korea, Republic of
ICH Related Training by CORE
James Leong, PhD, MPharm
Head,Health Products & Regulatory Science Centre of Regulatory Excellence (CoRE), Duke NUS Medical School, Singapore
Have an account?